Coloplast A/S (CLPBY)
12.56
+0.20
(+1.62%)
USD |
OTCM |
May 17, 16:00
Coloplast Gross Profit Margin (Quarterly): 67.98% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 67.98% |
| December 31, 2023 | 68.18% |
| September 30, 2023 | 66.37% |
| June 30, 2023 | 65.86% |
| March 31, 2023 | 66.44% |
| December 31, 2022 | 67.91% |
| September 30, 2022 | 68.82% |
| June 30, 2022 | 69.21% |
| March 31, 2022 | 68.72% |
| December 31, 2021 | 68.29% |
| September 30, 2021 | 69.04% |
| June 30, 2021 | 68.98% |
| March 31, 2021 | 68.40% |
| December 31, 2020 | 67.67% |
| September 30, 2020 | 68.85% |
| June 30, 2020 | 67.21% |
| March 31, 2020 | 67.80% |
| December 31, 2019 | 68.17% |
| September 30, 2019 | 68.64% |
| June 30, 2019 | 67.91% |
| March 31, 2019 | 67.19% |
| December 31, 2018 | 67.18% |
| September 30, 2018 | 68.38% |
| June 30, 2018 | 66.51% |
| March 31, 2018 | 66.79% |
| Date | Value |
|---|---|
| December 31, 2017 | 67.41% |
| September 30, 2017 | 68.27% |
| June 30, 2017 | 67.79% |
| March 31, 2017 | 67.56% |
| December 31, 2016 | 68.71% |
| September 30, 2016 | 68.49% |
| June 30, 2016 | 68.15% |
| March 31, 2016 | 68.14% |
| December 31, 2015 | 68.54% |
| September 30, 2015 | 69.40% |
| June 30, 2015 | 67.68% |
| March 31, 2015 | 68.49% |
| December 31, 2014 | 68.56% |
| September 30, 2014 | 69.51% |
| June 30, 2014 | 68.35% |
| March 31, 2014 | 68.58% |
| December 31, 2013 | 68.33% |
| September 30, 2013 | 68.32% |
| June 30, 2013 | 68.05% |
| March 31, 2013 | 66.64% |
| December 31, 2012 | 67.36% |
| September 30, 2012 | 67.11% |
| June 30, 2012 | 67.89% |
| March 31, 2012 | 65.94% |
| December 31, 2011 | 65.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
65.86%
Minimum
Jun 2023
69.21%
Maximum
Jun 2022
68.02%
Average
68.17%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Genmab A/S | 95.53% |
| Ascendis Pharma A/S | 92.11% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 40.08% |
| Return on Assets | 11.55% |
| Return on Invested Capital | 14.88% |
| Profit Margin (Quarterly) | 19.01% |
| Operating Margin (Quarterly) | 27.19% |
| Return on Net Operating Assets | 12.04% |